Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function - PubMed (original) (raw)

Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function

Jennifer C Fleming et al. Exp Neurol. 2008 Dec.

Abstract

The extent of disability caused by spinal cord injury (SCI) relates to secondary tissue destruction arising partly from an intraspinal influx of neutrophils and monocyte/macrophages after the initial injury. The integrin alpha4beta1, expressed by these leukocytes, is a key to their activation and migration into/within tissue. Therefore, blocking this integrin's functions may afford significant neuroprotection. Rats were treated intravenously with a blocking monoclonal antibody (mAb) to the alpha4 subunit of alpha4beta1 at 2 and 24 h after thoracic clip-compression SCI. Anti-alpha4beta1 treatment significantly decreased neutrophil and monocyte/macrophage influx at 3 d by 47% and 53%, respectively, and decreased neutrophil influx by 61% at 7 d after SCI. Anti-alpha4beta1 treatment also significantly reduced oxidative activity in injured cord homogenates at 3 d. For example, myeloperoxidase activity decreased by 38%, inducible nitric oxide by 44%, dichlorofluorescein (marking free radicals) by 33% and lipid peroxidation (malondialdehyde) by 42%. At 2-8 weeks after SCI, motor function improved by up to 2 points on an open-field locomotor scale. Treated rats supported weight with their hind paws instead of sweeping. At 2-4 weeks after SCI, anti-alpha4beta1 treatment decreased blood pressure responses during autonomic dysreflexia by as much as 43% and, at 2-8 weeks, decreased mechanical allodynia elicited from the trunk and hind paw by up to 54% and 40%, respectively. This improved functional recovery correlated with spared myelin-containing white matter and >10-fold more bulbospinal serotonergic axons below the injury than were in controls. The significant neurological improvement offered by this neuroprotective strategy underscores the potential for an anti-integrin treatment for SCI.

PubMed Disclaimer

Similar articles

• An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury.
  Bao F, Chen Y, Schneider KA, Weaver LC. Bao F, et al. Exp Neurol. 2008 Dec;214(2):160-7. doi: 10.1016/j.expneurol.2008.09.006. Epub 2008 Sep 26. Exp Neurol. 2008. PMID: 18926823
• Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy.
  Fleming JC, Bao F, Chen Y, Hamilton EF, Gonzalez-Lara LE, Foster PJ, Weaver LC. Fleming JC, et al. J Neurosurg Spine. 2009 Nov;11(5):575-87. doi: 10.3171/2009.6.SPINE08915. J Neurosurg Spine. 2009. PMID: 19929361
• Autonomic dysreflexia after spinal cord injury: central mechanisms and strategies for prevention.
  Weaver LC, Marsh DR, Gris D, Brown A, Dekaban GA. Weaver LC, et al. Prog Brain Res. 2006;152:245-63. doi: 10.1016/S0079-6123(05)52016-8. Prog Brain Res. 2006. PMID: 16198705 Review.
• Omega-3 fatty acids and neurological injury.
  Michael-Titus AT. Michael-Titus AT. Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):295-300. doi: 10.1016/j.plefa.2007.10.021. Epub 2007 Nov 26. Prostaglandins Leukot Essent Fatty Acids. 2007. PMID: 18036801 Review.

Cited by

• Role of inflammation in neurological damage and regeneration following spinal cord injury and its therapeutic implications.
  Jin Y, Song Y, Lin J, Liu T, Li G, Lai B, Gu Y, Chen G, Xing L. Jin Y, et al. Burns Trauma. 2023 Feb 28;11:tkac054. doi: 10.1093/burnst/tkac054. eCollection 2023. Burns Trauma. 2023. PMID: 36873284 Free PMC article. Review.
• An update on the roles of circular RNAs in spinal cord injury.
  Ma X, Wang X, Ma X, Zhang X, Gong X, Sun R, Wong SH, Chan MTV, Wu WKK. Ma X, et al. Mol Neurobiol. 2022 Apr;59(4):2620-2628. doi: 10.1007/s12035-021-02721-2. Epub 2022 Feb 3. Mol Neurobiol. 2022. PMID: 35112318 Review.
• Spleen tyrosine kinase facilitates neutrophil activation and worsens long-term neurologic deficits after spinal cord injury.
  McCreedy DA, Abram CL, Hu Y, Min SW, Platt ME, Kirchhoff MA, Reid SK, Jalufka FL, Lowell CA. McCreedy DA, et al. J Neuroinflammation. 2021 Dec 24;18(1):302. doi: 10.1186/s12974-021-02353-2. J Neuroinflammation. 2021. PMID: 34952603 Free PMC article.
• β2 Integrin CD11d/CD18: From Expression to an Emerging Role in Staged Leukocyte Migration.
  Blythe EN, Weaver LC, Brown A, Dekaban GA. Blythe EN, et al. Front Immunol. 2021 Nov 8;12:775447. doi: 10.3389/fimmu.2021.775447. eCollection 2021. Front Immunol. 2021. PMID: 34858434 Free PMC article. Review.
• Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2.
  Brennan FH, Jogia T, Gillespie ER, Blomster LV, Li XX, Nowlan B, Williams GM, Jacobson E, Osborne GW, Meunier FA, Taylor SM, Campbell KE, MacDonald KP, Levesque JP, Woodruff TM, Ruitenberg MJ. Brennan FH, et al. JCI Insight. 2019 May 2;4(9):e98254. doi: 10.1172/jci.insight.98254. eCollection 2019 May 2. JCI Insight. 2019. PMID: 31045582 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • SciCrunch